Physician

Orysia Kozicky, MD

According to 2025 Medicare claims, Orysia Kozicky, MD (NPI: 1699121954) practices rheumatology in the Pittsburgh, PA market, with the plurality of this provider's patient population coming from Allegheny, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PITTSBURGH PHYSICIANS (NPI: 1295793487; TIN: 232919472) and primary practice location at 15215-3235.

Kozicky's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 157 traditional Medicare patients, billed 40,991 HCPCS/CPT codes, and received $309,667 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,462 prescription claims across 337 beneficiaries totaling $1,107,558 in drug costs, led by Humira(Cf) Pen (Adalimumab). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $554 to $1,107,558. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$155K$310K2022 Medicare payment: $44,627 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $223,946 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $309,667 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022466,626$44,627
202313826,873$223,946
202415740,991$309,667

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$554K$1.1M2016 Drug cost: $554 (USD; Tot_Drug_Cst)2017 Drug cost: $2,525 (USD; Tot_Drug_Cst)2018 Drug cost: $4,367 (USD; Tot_Drug_Cst)2021 Drug cost: $115,275 (USD; Tot_Drug_Cst)2022 Drug cost: $181,386 (USD; Tot_Drug_Cst)2023 Drug cost: $832,783 (USD; Tot_Drug_Cst)2024 Drug cost: $1,107,558 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R11$554
20171234$2,525
20181232$4,367
2019N/RN/RN/R
2020N/RN/RN/R
2021N/R27$115,275
202289236$181,386
20232511,185$832,783
20243371,462$1,107,558

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
96413Administration of chemotherapy into vein, 1 hour or less2665$93
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more75109$82
J0897Injection, denosumab, 1 mg211,740$20
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4560$12
96372Injection of drug or substance under skin or into muscle35119$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab561,708$404,710
Enbrel SureclickEtanercept27756$197,892
Orencia ClickjectAbatacept13364$72,953
Hydroxychloroquine SulfateHydroxychloroquine Sulfate16410,777$5,730
LeflunomideLeflunomide1085,537$5,718

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

FAQ

What Medicare data is available for Orysia Kozicky, MD?

Tedicare shows public-source Medicare data for Orysia Kozicky, MD (NPI 1699121954), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Orysia Kozicky, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Orysia Kozicky, MD?

Orysia Kozicky, MD is linked to UNIVERSITY OF PITTSBURGH PHYSICIANS (billing NPI 1295793487) in the available physician profile data.

Does Orysia Kozicky, MD have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.